| Literature DB >> 24856141 |
Gulsum Kayman-Kurekci1, Beril Talim2, Petek Korkusuz3, Nilufer Sayar4, Turkan Sarioglu5, Ibrahim Oncel6, Parisa Sharafi1, Hulya Gundesli1, Burcu Balci-Hayta1, Nuhan Purali7, Piraye Serdaroglu-Oflazer8, Haluk Topaloglu6, Pervin Dincer9.
Abstract
We performed genome-wide homozygosity mapping and mapped a novel myopathic phenotype to chromosomal region 1q25 in a consanguineous family with three affected individuals manifesting proximal and distal weakness and atrophy, rigid spine and contractures of the proximal and distal interphalangeal hand joints. Additionally, cardiomyopathy and respiratory involvement were noted. DNA sequencing of torsinA-interacting protein 1 (TOR1AIP1) gene encoding lamina-associated polypeptide 1B (LAP1B), showed a homozygous c.186delG mutation that causes a frameshift resulting in a premature stop codon (p.E62fsTer25). We observed that expression of LAP1B was absent in the patient skeletal muscle fibres. Ultrastructural examination showed intact sarcomeric organization but alterations of the nuclear envelope including nuclear fragmentation, chromatin bleb formation and naked chromatin. LAP1B is a type-2 integral membrane protein localized in the inner nuclear membrane that binds to both A- and B-type lamins, and is involved in the regulation of torsinA ATPase. Interestingly, luminal domain-like LAP1 (LULL1)-an endoplasmic reticulum-localized partner of torsinA-was overexpressed in the patient's muscle in the absence of LAP1B. Therefore, the findings suggest that LAP1 and LULL1 might have a compensatory effect on each other. This study expands the spectrum of genes associated with nuclear envelopathies and highlights the critical function for LAP1B in striated muscle.Entities:
Keywords: LAP1; Muscular dystrophy; Myopathy; TOR1AIP1
Mesh:
Substances:
Year: 2014 PMID: 24856141 DOI: 10.1016/j.nmd.2014.04.007
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296